- Truffle Capital Unveils the First Edition of the Truffle MedTech 10
Mar 18, 2026
PARIS, March 18, 2026--(BUSINESS WIRE)--Truffle Capital, a leading European venture capital firm whose mission is to support the creation and growth of companies capable of becoming global leaders, unveils the Truffle MedTech 10 index. This is the first ranking of the top ten publicly traded companies by market capitalization in the pre-commercial and early commercial interventional MedTech sector.
Using PitchBook (https://pitchbook.com) data as of March 12th, 2026, this list identifies companies developing medical technologies dedicated to interventional therapeutic procedures. The ranking focuses specifically on "pre-commercial" and "early commercial" listed companies with 2025 reported revenues below 10 million USD.
Ranking Company Stock market Market Cap ($M) HQ location Medical field 1 Pulse Biosciences NAS: PLSE 1,380 USA Cardiovascular 2 Anteris Technologies ASX/NAS: AVR 641 USA / Aus Cardiovascular 3 Jenscare HK: 9877 472 China Cardiovascular 4 Imricor ASX: IMR 440 USA Cardiovascular 5 EBR Systems ASX: EBR 235 USA Cardiovascular 6 Carvolix EPA: CVX 220 France Cardiovascular 7 ONWARD Medical EBR: ONWD 214 Netherlands Neuromodulation 8 Microbot Medical NAS: MBOT 183 USA Cardiovascular 9 Medinice WSE: ICE 91 Poland Cardiovascular 10 Creo Medical LON : CREO 78 UK Gastroenterology/
Pneumology/
Urology
Dominance of the Cardiovascular Sector
This first edition highlights a major trend: the predominance of the cardiovascular sector, which accounts for 8 out of 10 spots in the ranking. This concentration is driven by several key factors:
i. Major Medical Need: Cardiovascular pathologies remain a global health priority
ii. High Technology Adoption: Cardiac specialists (especially interventional cardiologists) are the most eager clinicians to adopt new technological solutions for new indications
iii. Massive Investment Dynamics: This field attracts the largest financing flows and remains a primary driver for M&A activity in the sector
Notably, no companies from the orthopedics sector appear in this first ranking.
USA in the Lead, Europe and China also represented
While the United States confirms its historical leadership with five represented companies -accounting for 75% of total market capitalizations of the Truffle MedTech 10 index and led by Pulse Biosciences ($1,380M)—the Truffle MedTech 10 index highlights notable geographic diversity. Europe demonstrates its competitiveness and capacity for innovation with the presence of France (Carvolix), the Netherlands and Switzerland (ONWARD Medical, HQ in Netherlands, R&D center in Switzerland), Poland (Medinice) and UK (Creo Medical). Finally, Jenscare’s 3rd place ranking, with a market capitalization of $472M, highlights the emergence of the Chinese sector.
Story Continues
Philippe Pouletty, M.D., Co-Founder and CEO of Truffle Capital, stated: "This inaugural Truffle MedTech 10 index highlights the vitality of interventional MedTech, particularly in the cardiovascular field which largely dominates this ranking. These 'pre-commercial' and ‘early commercial’ companies are future leaders whose products will transform clinicians’ and patients’ lives. Their growing market capitalization demonstrates investor confidence in their ability to transform standards of care, democratize complex procedures and improve patient life. While the United States confirms its leadership, the emergence of European players is promising."
***
About Truffle Capital Founded in 2001, Truffle Capital is an independent European Venture Capital firm specializing in disruptive technologies in the Life Sciences (Biotech, MedTech) and IT sectors (Fintech and Insurtech). Truffle Capital's mission is to support the creation and development of innovative companies capable of becoming the leaders of tomorrow.
Managed by Philippe Pouletty, M.D. and Bernard-Louis Roques, Co-founders and co-CEOs, Truffle Capital manages €500 million in assets. Truffle Capital raised over €1.2 billion since its creation and has supported more than 124 companies in the life sciences and digital technology sectors.
In 2025, Abivax, biotech founded and funded by Truffle, reached $10Bn market capitalization on NASDAQ following strong Phase III results in ulcerative colitis. Truffle Capital recently replicated this Business Builder model on the MedTech Carvolix, integrating autonomous AI-driven mini-robotics solutions for heart valve replacement and brain stroke treatment.
Website: https://www.truffle.com/
LinkedIn: https://www.linkedin.com/company/truffle-capital/
View source version on businesswire.com: https://www.businesswire.com/news/home/20260318140389/en/
Contacts
Truffle Capital
Jules Herlem | jules@truffle.com
trufflemedtech10@truffle.com
Media | Primatice
Thomas de Climens | thomasdeclimens@primatice.com
Armand Rigaudy | armandrigaudy@primatice.com
View Comments
- Eletrobras (AXIA) Is a Great Choice for 'Trend' Investors, Here's Why
Nov 12, 2025
Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the sustainability of a trend and profit from it.
Often, the direction of a stock's price movement reverses quickly after taking a position in it, making investors incur a short-term capital loss. So, it's important to ensure that there are enough factors -- such as sound fundamentals, positive earnings estimate revisions, etc. -- that could keep the momentum in the stock going.
Investors looking to make a profit from stocks that are currently on the move may find our "Recent Price Strength" screen pretty useful. This predefined screen comes handy in spotting stocks that are on an uptrend backed by strength in their fundamentals, and trading in the upper portion of their 52-week high-low range, which is usually an indicator of bullishness.
There are several stocks that passed through the screen and Eletrobras (AXIA) is one of them. Here are the key reasons why this stock is a solid choice for "trend" investing.
A solid price increase over a period of 12 weeks reflects investors' continued willingness to pay more for the potential upside in a stock. AXIA is quite a good fit in this regard, gaining 51.7% over this period.
However, it's not enough to look at the price change for around three months, as it doesn't reflect any trend reversal that might have happened in a shorter time frame. It's important for a potential winner to maintain the price trend. A price increase of 21.2% over the past four weeks ensures that the trend is still in place for the stock of this electric utility.
Moreover, AXIA is currently trading at 97.6% of its 52-week High-Low Range, hinting that it can be on the verge of a breakout.
Looking at the fundamentals, the stock currently carries a Zacks Rank #2 (Buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises -- the key factors that impact a stock's near-term price movements.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Story Continues
Another factor that confirms the company's fundamental strength is its Average Broker Recommendation of #1 (Strong Buy). This indicates that the brokerage community is highly optimistic about the stock's near-term price performance.
So, the price trend in AXIA may not reverse anytime soon.
In addition to AXIA, there are several other stocks that currently pass through our "Recent Price Strength" screen. You may consider investing in them and start looking for the newest stocks that fit these criteria.
This is not the only screen that could help you find your next winning stock pick. Based on your personal investing style, you may choose from over 45 Zacks Premium Screens that are strategically created to beat the market.
However, keep in mind that the key to a successful stock-picking strategy is to ensure that it produced profitable results in the past. You could easily do that with the help of the Zacks Research Wizard. In addition to allowing you to backtest the effectiveness of your strategy, the program comes loaded with some of our most successful stock-picking strategies.
Click here to sign up for a free trial to the Research Wizard today.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Centrais El?tricas Brasileiras SA (AXIA) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
View Comments
- EBR Systems to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Nov 11, 2025 · businesswire.com
SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world's only left ventricular wireless cardiac pacing device for heart failure, today announced that management will be participating at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 20, 2025, at The Westin Grand Central in New York, NY. About EBR Systems EBR Systems is a cardiac rhythm management company on a clear mission: to transform the lives of people with hea.
- EBR SYSTEMS TO PARTICIPATE AT THE CANACCORD GENUITY MEDTECH, DIAGNOSTICS AND DIGITAL HEALTH & SERVICES FORUM
Nov 11, 2025
SUNNYVALE, CALIF.--(BUSINESS WIRE)--EBR SYSTEMS, INC., DEVELOPER OF THE WORLD'S ONLY LEFT VENTRICULAR WIRELESS CARDIAC PACING DEVICE FOR HEART FAILURE, TODAY ANNOUNCED THAT MANAGEMENT WILL BE PARTICIPATING AT THE CANACCORD GENUITY MEDTECH, DIAGNOSTICS AND DIGITAL HEALTH & SERVICES FORUM ON THURSDAY, NOVEMBER 20, 2025, AT THE WESTIN GRAND CENTRAL IN NEW YORK, NY. ABOUT EBR SYSTEMS EBR SYSTEMS IS A CARDIAC RHYTHM MANAGEMENT COMPANY ON A CLEAR MISSION: TO TRANSFORM THE LIVES OF PEOPLE WITH HEA.
- Centrais Elétricas Brasileiras S.A. - Eletrobrás (EBR) Q3 2025 Earnings Call Transcript
Nov 8, 2025 · seekingalpha.com
Centrais Elétricas Brasileiras S.A. - Eletrobrás ( EBR ) Q3 2025 Earnings Call November 6, 2025 9:00 AM EST Company Participants Ivan de Souza Monteiro - President, CEO & President of Executive Board Eduardo Haiama - Executive VP of Finance & Investor Relations and Member of Executive Board Rodrigo Nascimento - EVP of Regulation, Inst.
- Elea Signs MoU With Tapestry to Enhance Assurance of Rio AI City's 1.5 GW Energy Capacity
Nov 6, 2025
Rio de Janeiro City Hall, Axia, and Light also participate in the agreement
RIO DE JANEIRO, Nov. 6, 2025 /PRNewswire/ -- Elea Data Centers, the leading Brazilian sustainable platform and the first to deploy artificial intelligence at scale in Latin America, announces a Memorandum of Understanding (MoU) with the Municipality of Rio de Janeiro, Companhia Carioca de Parcerias e Investimento (CCPar), Axia Energia (formerly known as Eletrobras), Light, and Tapestry – a team of X, the Moonshot Factory (Google's innovation lab).Elea Data Centers (PRNewsfoto/Elea Data Centers)
This key agreement formalizes a collaboration for Rio AI City, an initiative to transform Rio de Janeiro into one of the world's largest metropolitan green data center hubs, driving sustainable AI innovation and economic development within the community.
The MoU positions Elea at the forefront of Artificial Intelligence diffusion in Latin America, combining US-based technology with public-private efforts and capabilities.
The agreement also reflects a shared commitment to mobilize extensive human, financial, and technological resources, formalizing a collective effort to accelerate the project's success.
Tapestry's participation will bring AI capabilities, summing up to state-of-the-art, unparalleled know-how of Axia and the ability to deliver Light. Together, these companies serve as a reliable assurance of the metropolis's capacity to supply green energy to Elea's project.
"Partnering with Elea is really critical to making sure Tapestry and this Rio AI City vision can deliver on infrastructure that is thoughtfully built out and designed for purpose. That wouldn't be possible without having the thought partnership and leadership of Elea as we develop this work," said Page Crahan, General Manager of Tapestry. "It's been critical that Elea and the whole team have been thinking not just about building out infrastructure for data centers, but also about the role of the grid that serves the community. That's what Tapestry is really delighted about: we can think about both at the same time."
"Rio AI City is more than a data center; it's a testament to Brazil's future as a global leader in sustainable digital infrastructure and AI diffusion," said Alessandro Lombardi, President and Founder of Elea Data Centers. "This alliance underscores Elea's dedication to provide AI-ready platforms, with available green energy of giga size deliverable as soon as 2026. These partners are assuring that this capacity is here and ready."
Story Continues
Elea designed Rio AI City to launch with an initial 1.5 GW of certified renewable energy capacity, delivering immediately, and scaling up to 3.2 GW by 2032.
In August, Elea signed an MoU with the Rio de Janeiro City Hall and Oracle to implement initiatives related to Rio AI City.
About Elea Data Centers
Headquartered in Rio de Janeiro, Brazil, Elea Data Centers is Latin America's pioneering data center infrastructure platform on a mission to accelerate a responsible digital economy and to power AI diffusion.
Utilizing 100% renewable energy, and supported by Goldman Sachs in addition to local financial institutions, Elea operates a nationwide network of nine interconnected data center campuses in the most critical cities of Brazil, with the capacity and scale to accommodate the high-density cloud and AI deployment needs of Big Techs and large global or local enterprises. Elea is the world's bridgeway to Brazil, coupling local market expertise with high-performance solutions that ensure your business's successful entry into LATAM. For more information, visit www.eleadatacenters.com.Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/elea-signs-mou-with-tapestry-to-enhance-assurance-of-rio-ai-citys-1-5-gw-energy-capacity-302607345.html
View Comments
- Are Utilities Stocks Lagging Centrais Eltricas Brasileiras (EBR) This Year?
Oct 24, 2025
Investors interested in Utilities stocks should always be looking to find the best-performing companies in the group. Is Eletrobras (EBR) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Utilities sector should help us answer this question.
Eletrobras is a member of the Utilities sector. This group includes 109 individual stocks and currently holds a Zacks Sector Rank of #5. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Eletrobras is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for EBR's full-year earnings has moved 12.5% higher within the past quarter. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Based on the latest available data, EBR has gained about 75.7% so far this year. Meanwhile, the Utilities sector has returned an average of 18.8% on a year-to-date basis. As we can see, Eletrobras is performing better than its sector in the calendar year.
ENGIE - Sponsored ADR (ENGIY) is another Utilities stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 45.5%.
Over the past three months, ENGIE - Sponsored ADR's consensus EPS estimate for the current year has increased 5.2%. The stock currently has a Zacks Rank #2 (Buy).
Breaking things down more, Eletrobras is a member of the Utility - Electric Power industry, which includes 59 individual companies and currently sits at #58 in the Zacks Industry Rank. On average, stocks in this group have gained 19.4% this year, meaning that EBR is performing better in terms of year-to-date returns. ENGIE - Sponsored ADR is also part of the same industry.
Eletrobras and ENGIE - Sponsored ADR could continue their solid performance, so investors interested in Utilities stocks should continue to pay close attention to these stocks.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Centrais El?tricas Brasileiras SA (EBR) : Free Stock Analysis Report
ENGIE - Sponsored ADR (ENGIY) : Free Stock Analysis Report
Leer más
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Ver comentarios
- Are Utilities Stocks Lagging Centrais Eltricas Brasileiras (EBR) This Year?
Oct 24, 2025 · zacks.com
Here is how Eletrobras (EBR) and ENGIE - Sponsored ADR (ENGIY) have performed compared to their sector so far this year.
- Brazil's Eletrobras changes name to Axia Energia
Oct 22, 2025 · reuters.com
Brazilian power company Eletrobras announced on Wednesday it is changing its name to Axia Energia, in a development it said will not impact any contractual, business, or regulatory commitments established by the firm.
- Eletrobras Dumps Nuclear Baggage -- Batista Brothers Snatch It Up in $98M Power Play
Oct 16, 2025
This article first appeared on GuruFocus.
Centrais Eletricas Brasileiras SA (NYSE:EBR) just pulled off one of its most symbolic clean-ups since privatization selling its nuclear arm, Eletronuclear, to J&F Investimentos, the holding company run by Wesley and Joesley Batista. Through its energy arm Ambar Energia, J&F agreed to pay 535 million reais ($98.2 million) and take on 2.4 billion reais in related debt, effectively removing one of Eletrobras' most controversial assets. The deal marks a deliberate shift for South America's largest utility, which has long wanted to exit the nuclear business and refocus on its core power generation and transmission segments.
Warning! GuruFocus has detected 11 Warning Signs with EBR. Is EBR fairly valued? Test your thesis with our free DCF calculator.
Investors wasted no time rewarding the move. Eletrobras stock surged as much as 4.4% at the open in Sao Paulo, touching a record intraday high of 54.13 reais and extending its year-to-date gain to 52%. Portfolio managers called it the right kind of cleanup not for its financial impact, but for what it signals about management discipline. Greg Lesko of Deltec Asset Management said the sale removes a key overhang that had worried investors about future liabilities. Analysts at Ativa Investimentos and Morada Capital described the sale as the final fix to an Achilles' heel left over from the company's state-controlled era, bringing Eletrobras closer to a balance sheet unburdened by nuclear provisions and litigation risk.
For the Batistas, the timing looks opportunistic. Their energy arm Ambar, already Brazil's second-largest private gas-fired power generator, is layering in a nuclear portfolio with predictable long-term contracts. Eletronuclear operates the Angra 1 and Angra 2 plants totaling 1,990 megawatts and oversees the Angra 3 project still under development, with potential output across the three sites topping 3,400 megawatts, enough to supply over 10 million people. J&F sees upside through modernization and integration with its broader energy footprint. For Eletrobras, this deal could mark the moment it finally sheds the nuclear baggage that shadowed its privatization and emerges as a leaner, more focused utility built for the next cycle of Brazil's energy expansion.
View Comments
